• Open Access IconOpen Access
  • Cite Icon369
  • https://doi.org/10.1186/1750-1172-8-23Copy DOI Icon

Barth syndrome

Show More
  • Abstract
  • Highlights & Summary
  • PDF
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

First described in 1983, Barth syndrome (BTHS) is widely regarded as a rare X-linked genetic disease characterised by cardiomyopathy (CM), skeletal myopathy, growth delay, neutropenia and increased urinary excretion of 3-methylglutaconic acid (3-MGCA). Fewer than 200 living males are known worldwide, but evidence is accumulating that the disorder is substantially under-diagnosed. Clinical features include variable combinations of the following wide spectrum: dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), endocardial fibroelastosis (EFE), left ventricular non-compaction (LVNC), ventricular arrhythmia, sudden cardiac death, prolonged QTc interval, delayed motor milestones, proximal myopathy, lethargy and fatigue, neutropenia (absent to severe; persistent, intermittent or perfectly cyclical), compensatory monocytosis, recurrent bacterial infection, hypoglycaemia, lactic acidosis, growth and pubertal delay, feeding problems, failure to thrive, episodic diarrhoea, characteristic facies, and X-linked family history. Historically regarded as a cardiac disease, BTHS is now considered a multi-system disorder which may be first seen by many different specialists or generalists. Phenotypic breadth and variability present a major challenge to the diagnostician: some children with BTHS have never been neutropenic, whereas others lack increased 3-MGCA and a minority has occult or absent CM. Furthermore, BTHS was first described in 2010 as an unrecognised cause of fetal death. Disabling mutations or deletions of the tafazzin (TAZ) gene, located at Xq28, cause the disorder by reducing remodeling of cardiolipin, a principal phospholipid of the inner mitochondrial membrane. A definitive biochemical test, based on detecting abnormal ratios of different cardiolipin species, was first described in 2008. Key areas of differential diagnosis include metabolic and viral cardiomyopathies, mitochondrial diseases, and many causes of neutropenia and recurrent male miscarriage and stillbirth. Cardiolipin testing and TAZ sequencing now provide relatively rapid diagnostic testing, both prospectively and retrospectively, from a range of fresh or stored tissues, blood or neonatal bloodspots. TAZ sequencing also allows female carrier detection and antenatal screening. Management of BTHS includes medical therapy of CM, cardiac transplantation (in 14% of patients), antibiotic prophylaxis and granulocyte colony-stimulating factor (G-CSF) therapy. Multidisciplinary teams/clinics are essential for minimising hospital attendances and allowing many more individuals with BTHS to live into adulthood.

Loading PDF

Similar Papers
  • Front Matter
  • Citations4

Big data for a rare disease: Examining heart transplantation for left ventricular noncompaction in the United Network of Organ Sharing registry

  • Apr 04, 2015
  • The Journal of Heart and Lung Transplantation
  • Neal K Lakdawala
  • PDF
  • Research Article
  • Citations21

SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome

  • Jun 13, 2024
  • Scientific Reports
  • Silvia Russo +4
  • Discussion
  • Citations3

Noncompaction in Mitochondrial Disorders.

  • Dec 07, 2017
  • Circulation Research
  • Josef Finsterer
  • Research Article
  • Citations279

Molecular symmetry in mitochondrial cardiolipins

  • Sep 07, 2005
  • Chemistry and Physics of Lipids
  • Michael Schlame +4
  • Research Article
  • Citations49

X-linked fetal cardiomyopathy caused by a novel mutation in theTAZ gene

  • Jan 01, 2006
  • Prenatal Diagnosis
  • April N Brady +2
  • Research Article
  • Citations23

Genetic modifiers modulate phenotypic expression of tafazzin deficiency in a mouse model of Barth syndrome.

  • Mar 14, 2023
  • Human molecular genetics
  • Suya Wang +12
  • PDF
  • Research Article
  • Citations20

The antimicrobial propeptide hCAP-18 plasma levels in neutropenia of various aetiologies: a prospective study.

  • Jun 29, 2015
  • Scientific Reports
  • Ying Ye +6
  • Research Article
  • Citations247

The X-Linked Gene G4.5 Is Responsible for Different Infantile Dilated Cardiomyopathies

  • Oct 01, 1997
  • American journal of human genetics
  • Patrizia D'Adamo +14
  • Discussion

Advice in ABC of adolescence is potentially misleading

  • Mar 31, 2005
  • BMJ
  • Richard Quinton
  • Research Article
  • Citations9

Left ventricular noncompaction: A clinical and morphological study

  • Jan 01, 2016
  • Arkhiv patologii
  • L B Mitrofanova +6
  • Research Article
  • Citations3

Case report of Barth syndrome: a forgotten cause of cardiomyopathy.

  • Jul 01, 2021
  • European Heart Journal - Case Reports
  • Shiavax Rao +2
  • Research Article
  • Citations37

Growth and puberty in children with HIV infection

  • Jan 01, 2009
  • Journal of Endocrinological Investigation
  • E S Majaliwa +2
  • Research Article
  • Citations3

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome.

  • Mar 23, 2022
  • Journal of Visualized Experiments
  • Roberto Angelini +3
  • Research Article

Left Ventricular Noncompaction Complicated with Myocardial Infarction with Barth Syndrome in a Newborn

  • Jun 30, 2016
  • Soonchunhyang Medical Science
  • Gyeong Hee Yoo
  • Abstract

Molecular Dynamics Investigation into the Distribution of Cardiolipin Variants in Flat and Buckled Heterogeneous Bilayers

  • Feb 01, 2017
  • Biophysical Journal
  • Kevin J Boyd +2
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.